Barely Significant
← all excerpts

The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast.

Breast Cancer Res Treat · 2019 · PMC6533234 · PMID 30796653

Europe PMCDOI
1
hedged sentence
0.3300
closest p · 6.6× alpha
0.3300
boldest claim

The sentences

showed a trendP = 0.33not close (p > 0.1)
negative) showed a trend for a prognostic difference in BCM with 10-year FU (HR 0.56, 95% CI 0.17–1.8), but the evidence was very weak ( P = 0.33), and the effect was lost when analyzed with 25-year FU (HR 0.93, 95% CI 0.29-3.0, P = 0.90) (Table 4 ; Online Resource 1).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.